Clin2
NCT07542041Likely a fitRecruiting

Pancreatic Cancer Detection Using Advanced Tissue Analysis

Pancreatic CancerPancreatic NeoplasmsPancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Lesions Located at the Body or the Tail

Part of Cancer, Digestive system, Hormones & metabolism clinical trials.

This study tests a new way to analyze tiny samples of pancreatic tissue taken during a biopsy to better detect cancer. The method uses special technology to examine the physical properties of cells, which may help doctors diagnose pancreatic cancer more accurately.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years old or older
  • You can understand the study and sign a consent form
  • Your doctor has recommended a needle biopsy of a suspicious pancreatic growth
  • The pancreatic lesion (abnormal area) can be safely reached with a biopsy needle
  • You do not have any serious medical conditions that would make the biopsy unsafe for you

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07709052Not yet recruiting
Study of early markers for pancreatic cancer diagnosis

This study looks for markers in tumor tissue that could help find pancreatic cancer earlier. You may be able to join if you are having surgery for a suspected pancreatic tumor and the final diagnosis is a precancerous condition or pancreatic cancer.

NCT06166147Recruiting
Blood test for early detection of pancreatic cancer

This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.

Shanghai, Shanghai Municipality
NCT06456281Recruiting
Blood test for early pancreatic cancer detection

This trial uses a blood test (called cfDNA) to look for early signs of pancreatic cancer. It compares results from people with pancreatic cancer, precancerous changes, non-cancerous pancreatic conditions, and healthy individuals to improve early detection.

Shanghai, Shanghai Municipality
NCT02869802Recruiting
Study types of pancreatic cancer using tumor gene testing

This trial studies metastatic pancreatic cancer by taking a small tissue sample and analyzing its genes. It may help doctors better understand which cancer subtypes patients have, which can guide future treatment choices.

Calgary, Alberta
NCT03311776Recruiting
Study blood and tissue markers in pancreatic cancer

This study looks at “biomarkers” (test signals in tissue or blood) in people with pancreatic cancer. It may help researchers understand the disease better and find ways to predict or track it.

Herlev
NCT05195281Recruiting
Study changes in pancreatic cancer during treatment

This study follows how pancreatic cancer changes over time while you’re receiving treatment before surgery. It may help doctors understand how the cancer evolves and guide better future treatment choices.

Milan

Hear when a new Pancreatic cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.